期刊文献+
共找到585篇文章
< 1 2 30 >
每页显示 20 50 100
The inhibitory effects of Yigan Jiangzhi formula on hepatic metastasis of colorectal cancer 被引量:1
1
作者 Yuan-hong Zhao Qian-qian Niu +3 位作者 Quan-zheng Li Ji-hong Yin Yu Lu Zheng Li 《TMR Integrative Medicine》 2020年第9期1-8,共8页
Background:To observe the inhibitory effects of Yigan Jiangzhi formula(liver-supplementing lipid-lowering formula,YGJZF)on hepatic metastasis of colorectal cancer.Methods:The hepatic metastasis BALB-c mice model of co... Background:To observe the inhibitory effects of Yigan Jiangzhi formula(liver-supplementing lipid-lowering formula,YGJZF)on hepatic metastasis of colorectal cancer.Methods:The hepatic metastasis BALB-c mice model of colorectal cancer was established by injecting HCT-116 cell suspension following splenectomy.Next,we randomly divided BALB-c mice into 5 groups,which were blank group,model group(tumor only),traditional Chinese medicine group(YGJZF),western medicine group(capecitabine),combined group(YGJZF and capecitabine),respectively.After 14 days treatment,the effects of different treatments were evaluated the serological indicators were evaluated,including the levels of alanine transaminase,aspartate transaminase,triglyceride,total cholesterol and vascular endothelial growth factor(VEGF)by ELISA.Results:Except the blank group,the other groups showed diffuse hepatic metastasis.Compared with the model group,the total number and weight of the metastatic tumors as well as serological indicators in medicine-given groups were sharply reduced(P<0.05 for all)the combined group had better effects.The serum levels of these indicators showed no statistical difference among each medicine-given group(P>0.05),but the combined group has a remarkable decrease of all the indicators than in western medicine group.Conclusion:YGJZF not only can inhibit the hepatic metastasis of colorectal cancer in BALB-c mice,but also affect the levels of hepatic enzymes and lipids.Meanwhile,it can reduce the expression of VEGF.All these results indicate that YGJZF,which lowers down lipids and protects hepatic functions,has the potential to block VEGF pathway,contributing to the inhibition of hepatic metastasis. 展开更多
关键词 Yigan jiangzhi FORMULA Hepatic metastasis of COLORECTAL cancer LIFESTYLE Vascular ENDOTHELIAL growth factor LIPID-LOWERING
下载PDF
Xiaoyu Jiangzhi capsule protects against heart failure via Ca^(2+)/CaMKII signaling pathways in mice
2
作者 Jianwei Wu Yafang Tan +4 位作者 Dongyuan Kang Juan Yu Jianyong Qi Jiashin Wu Minzhou Zhang 《Journal of Traditional Chinese Medical Sciences》 CAS 2022年第3期289-297,共9页
Objective: Heart failure(HF), a worldwide health condition, is the result of many cardiovascular diseases.The traditional Chinese medicine(TCM) Xiaoyu Jiangzhi capsule(XYC) has long been in use in China to treat hyper... Objective: Heart failure(HF), a worldwide health condition, is the result of many cardiovascular diseases.The traditional Chinese medicine(TCM) Xiaoyu Jiangzhi capsule(XYC) has long been in use in China to treat hyperlipidemia and inhibit platelet aggregation. This study explores the effects of XYC on heart failure(HF) and its detailed mechanisms.Methods: Isoproterenol(ISO, 30 mg/kg) was injected intraperitoneally for 7 days to copy a HF model of 10-12 weeks old, 20-30 g male mice. We then compared the CON(control) group, ISO(HF model)group, MET(metoprolol) group, and XYC group. Cardiac systolic function and left wall thickness were evaluated by echocardiograph. Using western blot analysis, we detected the proteins of calmodulin dependent protein kinase Ⅱ(Ca MKII) and sarco/endoplasmic reticulum Ca^(2+)-ATPase(Serca). Furthermore, ts A201 cells were cultured and the human CaV1.2 calcium channel current(hCaV1.2) were detected by patch clamp experiments.Results: XYC reduced HF, inhibiting the protein expression of Ca MKII, but Serca did not change significantly. Moreover, XYC inhibited the peak amplitude of the hCaV1.2 current, depolarizing shifted the activation curve 27.6 mV, and shifted the inactivation curve toward a positive potential 17.6 mV. The fraction recovered from inaction was reduced in XYC group compared with that in CON group.Conclusion: XYC could inhibit ISO-induced HF by reducing the Ca^(2+)/Ca MKII signaling pathway in mice. 展开更多
关键词 Heart failure CaV1.2 channel Patch clamp CAMKII SERCA Traditional Chinese medicine Xiaoyu jiangzhi capsule MICE
下载PDF
Effect of the adjuvant Baogan Jiangzhi decoction therapy on liver function and insulin sensitivity in patients with nonalcoholic fatty liver disease
3
作者 Hong-Mei Qiang Jun-Wei Tang +1 位作者 Rong Zhao Ming-Xuan Wang 《Journal of Hainan Medical University》 2018年第6期55-58,共4页
Objective:To study the effect of the adjuvant Baogan Jiangzhi decoction therapy on liver function and insulin sensitivity in patients with nonalcoholic fatty liver disease.Methods: Patients who were newly diagnosed wi... Objective:To study the effect of the adjuvant Baogan Jiangzhi decoction therapy on liver function and insulin sensitivity in patients with nonalcoholic fatty liver disease.Methods: Patients who were newly diagnosed with nonalcoholic fatty liver disease in Nanchong Central Hospital and Suining Central Hospital between March 2015 and October 2017 were selected and randomly divided into the observation group who accepted Baogan Jiangzhi decoction combined with conventional western medicine treatment and the control group who accepted conventional western medicine treatment. The contents of liver damage indexes, inflammatory response markers and oxidative stress markers in serum as well as the expression of insulin signaling molecules in peripheral blood were measured before treatment and 2 weeks after treatment.Results:ALT, AST,γ-GT, TBIL, Chemerin, Wnt5a,β-catenin, MDA and NO contents in serum of both groups 2 weeks after treatment were lower than those before treatment whereas APN, Ghrelin, T-AOC and SOD contents in serum as well as IRS1, IRS2 and GLUT4 expression in peripheral blood were higher than those before treatment, and compared with those of control group, ALT, AST,γ-GT, TBIL, Chemerin, Wnt5a,β-catenin, MDA and NO contents in serum of observation group 2 weeks after treatment were lower whereas APN, Ghrelin, T-AOC and SOD contents in serum as well as IRS1, IRS2 and GLUT4 expression in peripheral blood were higher.Conclusion: Adjuvant Baogan Jiangzhi decoction therapy for nonalcoholic fatty liver disease can reduce liver function injury and improve insulin sensitivity. 展开更多
关键词 NONALCOHOLIC FATTY liver disease Baogan jiangzhi DECOCTION INSULIN resistance INFLAMMATORY response
下载PDF
Clinical observation of Jiangzhi Hugan Recipe combined with rosuvastatin calcium tablets in the treatment of non-alcoholic fatty liver disease
4
作者 Cheng-Hui Zhu Guan-Hua Lu +5 位作者 Xi-Liang Sun Xi Cao Li-Dan Wang Jin-Ling Jia Wei Du Xiao-Fei Zhang 《Journal of Hainan Medical University》 2019年第1期14-17,共4页
Objective:To investigate the influence of integrated traditional Chinese and Western medicine on the related indexes and TCM syndrome scores of patients with non-alcoholic fatty liver disease.Methods: A total of 128 p... Objective:To investigate the influence of integrated traditional Chinese and Western medicine on the related indexes and TCM syndrome scores of patients with non-alcoholic fatty liver disease.Methods: A total of 128 patients with non-alcoholic fatty liver disease who were admitted to our department from January 2017 to May 18, 2017 were enrolled in the study. According to the hospital admission record number, they were randomly divided into treatment groups (64 cases). and the control group (64 cases). The control group was treated with rosuvastatin calcium tablets. The treatment group was treated with Jiangzhi Fanggan Recipe on the basis of the control group. The treatment was performed for 10 d for a total of 3 courses. Comparison of liver function, blood lipids, insulin resistance index (HOMA-IR), iris (Irisin), superoxide dismutase (SOD), malondialdehyde (MDA), body mass index (BMI), waist circumference (WC), Liver/spleen CT ratio and TCM syndrome scores.Results: The curative effect of TCM symptom in the treatment group (82.82%) was significantly higher than that in the control group (65.62%), and the difference was statistically significant. There was no difference between the two groups before treatment. Compared with before treatment, the levels of each index were significantly improved after treatment, and the improvement of the treatment group was more significant than that of the control group.Conclusion: The combination of traditional Chinese and Western medicine can improve the symptoms of patients, achieve good clinical efficacy, and have certain anti-oxidative stress effects, which is worthy of clinical promotion or further research. 展开更多
关键词 NONALCOHOLIC fatty liver PHLEGM and blood STASIS jiangzhi Hugan RECIPE ROSUVASTATIN calcium TABLETS Oxidative stress
下载PDF
Bioactivity of five components of Chinese herbal formula Jiangzhi granules against hepatocellular steatosis 被引量:17
5
作者 Hai-yan Song Li Zhang +2 位作者 Jie-lu Pan Li-li Yang Guang Ji 《Journal of Integrative Medicine》 SCIE CAS CSCD 2013年第4期262-268,共7页
OBJECTIVE: This study aims to evaluate the bioactivity of five components of the traditional Chinese medicine complex prescription Jiangzhi granules against hepatocellular steatosis. METHODS: The five major components... OBJECTIVE: This study aims to evaluate the bioactivity of five components of the traditional Chinese medicine complex prescription Jiangzhi granules against hepatocellular steatosis. METHODS: The five major components, including protopanaxadiol, tanshinone IIA, emodin, chlorogenic acid, and nuciferine, were extracted from Jiangzhi granules. Their cytotoxicity was assessed to determine the safe dose of each component for HepG2 cells. HepG2 cellular steatosis was induced using 1 mmol/L of free fatty acids (FFAs) for 24 h, and then treated with each component at high, intermediate, and low doses (500, 50, and 5 μmol/L), respectively for another 24 h. The effects on HepG2 steatosis were observed directly under optical phase microscopy, or through oil red O staining and Nile red assays. In addition, the levels of reactive oxygen species (ROS) in the steatotic HepG2 cells with and without high-dose protopanaxadiol treatment were measured using fluorescent dye 2′,7′-dichlorodihydrofluorescein diacetate staining. RESULTS: No obvious cytotoxicity was observed in the HepG2 cells incubated with each of the five components at up to 500 μmol/L. At 24 h after incubation with FFAs, the HepG2 cells swelled and many lipid droplets accumulated. The lipid content was attenuated after 24 h of incubation with protopanaxadiol, tanshinone IIA, and emodin at 500 or 50 μmol/L (P<0.05), especially with 500 μmol/L protopanaxadiol (P<0.01). In addition, the ROS level was elevated in steatotic cells, but decreased after intervention with 500 μmol/L protopanaxadiol (P<0.05). CONCLUSION: Protopanaxadiol, tanshinone IIA, and emodin alleviate hepatocellular steatosis in a dose-dependent manner, and oxidative stress regulation may partially contribute to the effects of protopanaxadiol. 展开更多
关键词 游离脂肪酸 组成部分 生物活性 肝细胞 颗粒 降脂 HEPG2细胞 人参二醇
下载PDF
Effect of Tongmai Jiangzhi Oral Liquid (通脉降脂口服液) on Serum P-selectin, von Willebrand Factors and D-Dimer in Patients with Atherosclerosis 被引量:1
6
作者 沈晓君 史云菊 王玲 《Chinese Journal of Integrated Traditional and Western Medicine》 2004年第4期263-266,共4页
Objective: To explore the role of cytokines on the pathogenesis of atherosclerosis, and the lectins (Ps), von Willebrand (vWF), and D-dimer (D-D) in atherosclerosis (AS) patients. Methods: Sixtythree AS patients were ... Objective: To explore the role of cytokines on the pathogenesis of atherosclerosis, and the lectins (Ps), von Willebrand (vWF), and D-dimer (D-D) in atherosclerosis (AS) patients. Methods: Sixtythree AS patients were randomly divided into the treated group ( n = 33, treated with TMJZ, 10 ml each time, three times a day) and the control group (n = 30, treated with Lovastatin, 10 mg, once daily). The levels of serum lipids (enzymatic methods), Ps, vWF, and D-D were measured before and after 8 weeks of treatment. Results: Serum total cholesterol (TC), triglyceride (TG), low-density lipoprotein cholesterol (LDL-C), apo-protein B-100 (apoB-100) were significantly decreased (P<0.05 or P< 0.01) and high-density lipoprotein cholesterol (HDL-C) was significantly raised (P<0.05) after TM JZ treatment. Serum Ps,vWF, and D-D also declined (P<0.05) after treatment. There was no significant difference between the treated and the control groups in these parameters except serum HDL-C level. Conclusion: TMJZ has good therapeutic effect in regulating serum lipids, improving endothelial cell function, inhibiting activation of platelets, and preventing the disturbance of blood coagulation/fibrinolysis function in patients with AS. 展开更多
关键词 D-DIMER P-SELECTIN 降脂 口服液 HDL-C LDL-C TG TC
下载PDF
Efficacy of Jiangzhi Xiaoban tablet(降脂消斑片)on toll-like receptor 4/nuclear factor-kappa B/nod-like receptor protein 3 signaling pathway in mice with atherosclerosis induced by high-fat diet
7
作者 LIU Huihui FENG Jun +2 位作者 LIU Jianhe CHENG Choufu HU Guoheng 《Journal of Traditional Chinese Medicine》 SCIE CSCD 2024年第1期88-94,共7页
OBJECTIVE:To study the effect of Jiangzhi Xiaoban tablet(降脂消斑片,JZXB)on toll-like receptor 4(TLR4)/nuclear factor-kappa B(NF-κB)/Nod-like receptor protein 3(NLRP3)signaling pathway expression in atherosclerosis(A... OBJECTIVE:To study the effect of Jiangzhi Xiaoban tablet(降脂消斑片,JZXB)on toll-like receptor 4(TLR4)/nuclear factor-kappa B(NF-κB)/Nod-like receptor protein 3(NLRP3)signaling pathway expression in atherosclerosis(AS)mice by establishing a mouse model of AS,and to explore its mechanism of prevention and treatment of AS.METHODS:Sixty-four male C57BL/6J mice were randomly divided into two groups,12 in the normal control group and 52 in the model group(MOD).Seven weeks later,two mice in each of the above two groups were randomly sacrificed,and the whole aortic tissue of the mice was taken out for hematoxylin-eosin staining.After successful modeling,50 mice in the modeling group were randomly divided into 5 groups:MOD,atorvastatin group(ATO),low-dose group of JZXB(JZXB-L),middle-dose group of JZXB(JZXB-M),and high-dose group of JZXB(JZXB-H),10 mice in each group.The mice in each group were killed after 6 weeks of preventive administration.HE staining was used to observe the pathological changes of aorta in AS mice.The levels of serum triglyceride(TG),total cholesterol(TC),low-density lipoprotein cholesterol(LDL-C)and high-density lipoprotein cholesterol(HDL-C)were detected by automatic biochemical analyzer.The levels of inflammatory factor interleukin-1β(IL-1β)were detected by enzyme linked immunosorbent assay.The expression of TLR4,NF-κB and NLRP3 proteins in aortic tissue was detected by immunohistochemistry.RESULTS:Compared with the MOD,the levels of serum TC,TG and LDL-C in the JZXB-H and ATO were significantly decreased,while the level of HDL-C was significantly increased.The levels of serum TG,LDL-C in the JZXB-M were significantly decreased,and the level of HDL-C was significantly increased.Compared with the MOD,the levels of IL-1βwere significantly decreased,aortic lesions were significantly improved,and the expression of TLR4,NF-κB,and NLRP3 proteins in the aortic tissue was significantly decreased in the JZXB-H,JZXB-M,and ATO.CONCLUSION:JZXB has inhibitory effect on atherosclerosis in mice,and its mechanism may be through regulating the TLR4/NF-κB/NLRP3 signaling pathway and reducing the inflammatory response,so as to play a role in inhibiting atherosclerosis. 展开更多
关键词 ATHEROSCLEROSIS toll-like receptor 4 NF-kappa B NLR proteins signal transduction INFLAMMATION jiangzhi Xiaoban tablet
原文传递
基于肠-肝轴探讨清肝降脂方对代谢相关脂肪性肝病大鼠肠道屏障的作用研究
8
作者 李莹 闵冬雨 +4 位作者 郭文昭 马小敏 杨子轩 卢秉久 张明香 《实用中医内科杂志》 2024年第2期97-100,I0005,I0006,共6页
目的基于肠-肝轴理论探讨清肝降脂方对高脂饲料诱导的代谢相关脂肪性肝病(MAFLD)大鼠肠道屏障的作用。方法60只SPF级雄性SD大鼠,随机抽取10只作为正常组,余下作为高脂饮食组,给予高脂饲料喂养8周。造模成功后,将高脂饮食组大鼠随机分为... 目的基于肠-肝轴理论探讨清肝降脂方对高脂饲料诱导的代谢相关脂肪性肝病(MAFLD)大鼠肠道屏障的作用。方法60只SPF级雄性SD大鼠,随机抽取10只作为正常组,余下作为高脂饮食组,给予高脂饲料喂养8周。造模成功后,将高脂饮食组大鼠随机分为模型组和中药低剂量组、中剂量组、高剂量组及水林佳组。观察各组大鼠肝脏及回肠末端组织病理变化、血清生化学及血清内毒素水平,回肠组织中紧密连接蛋白ZO-1、Occludin表达情况。结果与正常组比较,模型组大鼠肝脏和回肠组织可见明显病理损伤,血清ALT、TC、TG、LDL-C及血清LPS水平表达量均明显增高,均具有统计学意义(P<0.05),回肠组织中ZO-1、Occludin蛋白阳性表达降低(P<0.05)。与模型组比较,水林佳组和中药高、中剂量均能明显降低ALT、TC、TG水平,降低LDL-C含量(P<0.05)。水林佳及中药组大鼠血清LPS水平均明显低于模型组(P<0.05),水林佳组以及中药高、中剂量组ZO-1、Occludin蛋白阳性表达增多,中药低剂量组蛋白表达略增加。结论清肝降脂方可以调节大鼠脂质代谢,修复肠道紧密连接,维持正常肠道黏膜屏障功能,阻止肠内炎性因子、内毒素等进入肝脏,提示清肝降脂方治疗MAFLD作用机制可能与调节肠-肝轴、改善肠道免疫屏障有关。 展开更多
关键词 代谢相关脂肪性肝病 清肝降脂方 肠-肝轴 肠黏膜屏障
原文传递
联合运用降脂通脉胶囊治疗血脂异常疗效及安全性的Meta分析
9
作者 赵哲俊 孙元隆 +3 位作者 王肖龙 李琳 黄程新 贾美君 《中西医结合心脑血管病杂志》 2024年第7期1204-1212,共9页
目的:评价联合运用降脂通脉胶囊治疗血脂异常的临床疗效及安全性。方法:计算机检索维普(VIP)、中国知网(CNKI)、万方(WanFang Data)、中国生物医学文献数据库(CBM)、PubMed、the Cochrane Library、EMbase等收录的有关联合运用降脂通脉... 目的:评价联合运用降脂通脉胶囊治疗血脂异常的临床疗效及安全性。方法:计算机检索维普(VIP)、中国知网(CNKI)、万方(WanFang Data)、中国生物医学文献数据库(CBM)、PubMed、the Cochrane Library、EMbase等收录的有关联合运用降脂通脉胶囊治疗血脂异常的随机对照试验(RCT)。检索时限为建库至2022年9月采用Cochrane评价手册中的偏倚风险评估工具进行评估,并使用RevMan 5.4.1与Stata 14.0软件进行Meta分析,系统评价降脂通脉胶囊对总胆固醇(TC)、三酰甘油(TG)、低密度脂蛋白胆固醇(LDL-C)、高密度脂蛋白胆固醇(HDL-C)、颈动脉内中膜厚度(IMT)及颈动脉斑块积分的影响。结果:共纳入11项RCT,涉及914例血脂异常病人。采用降脂通脉胶囊联合常规西药治疗的试验组TC[MD=-0.69,95%CI(-0.98,-0.40),P<0.00001]、LDL-C[MD=-0.52,95%CI(-0.74,-0.31),P<0.00001]、TG[MD=-0.47,95%CI(-0.67,-0.26),P<0.00001]、IMT[MD=-0.27,95%CI(-0.33,-0.22),P<0.00001]与颈动脉斑块积分[MD=-1.43,95%CI(-2.33,-0.63),P=0.0004]水平较采用常规西药治疗的对照组明显降低,HDL-C[MD=0.20,95%CI(0.07,0.32),P=0.002]水平与临床疗效[OR=3.49,95%CI(2.11,5.76),P<0.00001]较对照组明显提高。两组不良反应发生率比较差异无统计学意义[OR=1.25,95%CI(0.59,2.65),P=0.57]。结论:现有证据表明,加用降脂通脉胶囊治疗血脂异常效果优于单纯西药常规治疗。 展开更多
关键词 高血脂 血脂异常 降脂通脉胶囊 META分析
下载PDF
基于质量源于设计理念的降脂护肝方提取工艺研究
10
作者 吴作敏 李恒 +5 位作者 王韵旨 宁萌 郭丽 李宜涵 金少举 王瑞 《中南药学》 CAS 2024年第4期984-990,共7页
目的 基于质量源于设计理念,优化降脂护肝方的提取工艺。方法 以提取次数、提取时间、加水倍量为关键工艺参数(CPPs),应用正交设计从黄芪甲苷、甜菜碱、多糖含量及出膏率4项潜在关键质量属性(CQAs)中筛选CPPs对应的CQAs,通过Box-Behnke... 目的 基于质量源于设计理念,优化降脂护肝方的提取工艺。方法 以提取次数、提取时间、加水倍量为关键工艺参数(CPPs),应用正交设计从黄芪甲苷、甜菜碱、多糖含量及出膏率4项潜在关键质量属性(CQAs)中筛选CPPs对应的CQAs,通过Box-Behnken设计确定CQAs,并建立数学模型分析CPPs与CQAs之间的交互作用,最后建立设计空间并验证。结果 根据Box-Behnken试验确定甜菜碱的含量与出膏率为CQAs。通过设计空间的优化,得到最佳提取工艺为加10倍量水,提取3次,每次1.5 h。结论 本研究优选的提取工艺稳定可靠,可为降脂护肝方的制备及质量控制提供参考。 展开更多
关键词 质量源于设计 降脂护肝方 提取工艺 BOX-BEHNKEN设计 设计空间
原文传递
益脉降脂汤含药血清对THP-1源性泡沫细胞模型miRNA差异表达分析
11
作者 赖春冰 古展鑫 刘锐 《海南医学院学报》 CAS 北大核心 2024年第3期183-191,共9页
目的:探讨益脉降脂汤含药血清干预THP-1源性泡沫细胞模型后差异表达miRNA及相关生物功能、信号通路。方法:实验分为巨噬细胞组、泡沫细胞模型组、益脉降脂含药血清组,以佛波酯对THP-1细胞诱导为巨噬细胞,经诱导分化的巨噬细胞给予ox-LD... 目的:探讨益脉降脂汤含药血清干预THP-1源性泡沫细胞模型后差异表达miRNA及相关生物功能、信号通路。方法:实验分为巨噬细胞组、泡沫细胞模型组、益脉降脂含药血清组,以佛波酯对THP-1细胞诱导为巨噬细胞,经诱导分化的巨噬细胞给予ox-LDL建立泡沫细胞模型,以益脉降脂汤大鼠血清干预泡沫细胞。提取各组细胞Total RNA进行miRNA测序,筛选差异表达miRNA,预测相关靶基因后进行GO分析、KEGG分析,建立蛋白互作网络、miRNA-靶基因互作网络,RT-qPCR验证改善动脉粥样硬化可能信号通路。结果:空白组与模型组差异miRNA为hsa-miR-302c-3p、hsa-miR-302d-3p、hsa-miR-30d-3p、hsa-miR-3189-3p、hsa-miR-374b-5p、hsa-miR-423-5p、hsa-miR-4781-3p、hsa-miR-663a;模型组和益脉降脂含药血清组差异miRNA为hsa-miR-3150a-3p、hsa-miR-7704、hsa-miR-877-3p、hsa-miR-150-5p、hsa-miR-423-5p、hsa-miR-374c-3p、hsa-miR-374b-5p;模型组与益脉降脂含药血清组差异miRNA预测靶基因显示主要富集于MAPK信号通路、ErbB信号通路、Hippo信号通路、Wnt信号通路等信号通路;SCN1A、PRKACA、MECP2、EIF4E、SRSF1、MBNL1、PRKCA、PPARGC1A可能是益脉降脂汤含药血清向THP-1源性泡沫细胞发挥作用潜在关键靶标。结论:hsa-miR-374c-3p、hsa-miR-423-5p、hsa-miR-374b-5p是益脉降脂汤含药血清作用于泡沫细胞重要的miRNAs,差异表达显著的miRNA以及显著富集的相关信号通路可为诊断和治疗动脉粥样硬化提供新的思路。 展开更多
关键词 益脉降脂汤 泡沫细胞 miRNA测序 生物信息学
下载PDF
Bushen Jiangzhi formula reduces atherosclerosis in apoE-/-mice through autophagy 被引量:3
12
作者 Cao Hui Jia Qingling +4 位作者 Shen Dingzhu Yan Li Chen Chuan Xing Sanli Dou Fangfang 《Journal of Traditional Chinese Medicine》 SCIE CAS CSCD 2020年第4期593-601,共9页
OBJECTIVE:To study the effect of Bushen Jiangzhi formula(BSJZF)on atherosclerosis(AS)in apolipoprotein E knockout(apoE^-/-)mice and the underlying mechanism.METHODS:We used a high fat diet to induce AS in apoE^-/- mic... OBJECTIVE:To study the effect of Bushen Jiangzhi formula(BSJZF)on atherosclerosis(AS)in apolipoprotein E knockout(apoE^-/-)mice and the underlying mechanism.METHODS:We used a high fat diet to induce AS in apoE^-/- mice.The mice were randomly divided into four groups:model,BSJZF,atorvastatin,and 3-methyladenine groups.Syngeneic C57BL/6 mice of the same age were used for the control group.Autophagosomes in the aorta were examined by transmission electron microscopy.Morphology,lipid accumulation,and collagen deposition in the aorta were examined by hematoxylin and eosin,Oil Red O,and Masson's staining,respectively.Serum levels of tumor necrosis factor alpha(TNF-α),interferon gamma(IFN-γ),and interleukin 10(IL-10)were measured by enzyme-linked immunoassays.Protein expression of microtubule-associated protein light chain 3(LC3),Beclin 1,and p62 in the aorta were examined by Western blot analyses.RESULTS:ApoE^-/- mice fed a high fat diet exhibited AS symptoms including less autophagosomes in the aorta,higher serum levels of TNF-α,IFN-γ,and p62,and lower serum levels of IL-10,LC3,and Beclin 1.Treatment with BSJZF significantly reduced the area of the aortic plaque,decreased expression of TNF-α,IFN-γ,and p62,and increased expression of IL-10,LC3,and Beclin 1.CONCLUSION:Our findings suggest that BSJZF promotes autophagy and reduces inflammation by regulating the expression of autophagy-related proteins LC3,Beclin 1,and p62,thereby effectively treating AS. 展开更多
关键词 ATHEROSCLEROSIS AUTOPHAGY Inflammation Tumor necrosis factor alpha INTERFERON-GAMMA INTERLEUKIN-10 Bushen jiangzhi formula
原文传递
健脾理气降脂汤治疗单纯性肥胖临床观察
13
作者 黄谦 袁通立 《山西中医》 2024年第2期19-20,24,共3页
目的:观察健脾理气降脂汤治疗单纯性肥胖的临床疗效。方法:选取符合纳入标准的60例脾虚湿阻型单纯性肥胖患者,随机分为两组各30例。对照组予单纯的饮食运动干预,治疗组在对照组基础上予健脾理气降脂汤口服,疗程12周。分析两组患者治疗... 目的:观察健脾理气降脂汤治疗单纯性肥胖的临床疗效。方法:选取符合纳入标准的60例脾虚湿阻型单纯性肥胖患者,随机分为两组各30例。对照组予单纯的饮食运动干预,治疗组在对照组基础上予健脾理气降脂汤口服,疗程12周。分析两组患者治疗效果、安全性、血清总胆固醇(TC)、甘油三酯(TG)、体重、体质指数(BMI)、腰围、臀围。结果:治疗组的总有效率为96.67%高于对照组的70.00%,差异有统计学意义(P<0.05)。治疗后,治疗组体重、体质指数(BMI)、腰围、臀围、血清总胆固醇(TC)、甘油三酯(TG)水平均低于对照组,且组内前后比较差异有统计学意义(P<0.05)。结论:健脾理气降脂汤治疗脾虚湿阻型单纯性肥胖,可明显改善患者体重、腰围、臀围,降低血清总胆固醇(TC)、甘油三酯(TG)水平,疗效较好。 展开更多
关键词 单纯性肥胖 脾虚湿阻 健脾理气降脂汤 中医药治疗
下载PDF
马红学主任医师从痰湿论治非酒精性脂肪性肝病临证撷粹
14
作者 贺鹏飞 张静 马红学 《光明中医》 2024年第3期574-577,共4页
非酒精性脂肪性肝病是一种肝脏损伤疾病,会进一步发展成非酒精性脂肪肝炎、肝硬化和肝癌等疾病。随着经济发展和饮食结构的改变,该病患病率逐年上升,严重危害人类健康。目前西医学对该病治疗尚无特效药,而中医药在治疗上具有独特优势。... 非酒精性脂肪性肝病是一种肝脏损伤疾病,会进一步发展成非酒精性脂肪肝炎、肝硬化和肝癌等疾病。随着经济发展和饮食结构的改变,该病患病率逐年上升,严重危害人类健康。目前西医学对该病治疗尚无特效药,而中医药在治疗上具有独特优势。马红学主任医师在习得前人的治疗经验上,从痰湿方面论治此病有自己的独到见解,并创健脾降脂饮治疗非酒精性脂肪性肝病,取得显著疗效。 展开更多
关键词 肝癖 非酒精性脂肪性肝病 痰湿论治 健脾降脂饮
下载PDF
Quantitative determination of multi-class bioactive constituents for quality control of Yiqi Jiangzhi Granules
15
作者 Shaobo Guo Shaowei Hu +4 位作者 Lijuan Jiang Xiaohe Chen Wei Zhang Yanyan Jiang Bin Liu 《Chinese Herbal Medicines》 CAS 2022年第2期324-331,共8页
Objective:To establish a reliable and sensitive method for evaluating quality of Yiqi Jiangzhi Granules(YQJZG).Methods:Ultra performance liquid chromatography electrospray ionization tandem mass spectrometry(UPLC-ESI-... Objective:To establish a reliable and sensitive method for evaluating quality of Yiqi Jiangzhi Granules(YQJZG).Methods:Ultra performance liquid chromatography electrospray ionization tandem mass spectrometry(UPLC-ESI-MS/MS)was employed for simultaneous determination of eight marker components.Separation was performed on an AQUITY UPLC;HSS T3 column,the mobile phase consisted of acetonitrile as the organic phase and 0.1%(volume percentage)formic acid as the aqueous.Eight marker components,ginsenoside Rg1(GRg1),ginsenoside Re(GRe),ginsenoside Rb1(Gb1),typhaneoside(TEO),isorhamnetin-3-O-neohespeidoside(IN),hesperidin(HPD),aurantio-obtusin-6-O-β-D-glucoside(AG)and curcumin(CCM),were detected by multiple reaction monitoring(MRM)mode.The Chinese Pharmacopoeia(2020 edition)was regarded as the guidance document for this method validation.Results:The method showed good linearity(R^(2)≥0.9990).The relative standard deviation(RSD)values for the instrument precision,intermediate precision and repeatability were less than 2.91%,2.88%,and 3.54%,respectively.The average recovery varied from 91.08%to 103.89%,with RSD below 3.81%.Sample solutions were found to be stable within 24 h at 4℃(RSD<2.85%).Eight marker components were successfully determined from three batches of YQJZG.Conclusion:The proposed UPLC-ESI-MS/MS method was found to be simple,fast and sensitive,and can be used for the routine quality assessment of YQJZG.Simultaneously,this method may provide a new and powerful tool of quality control for other traditional Chinese medicine analogous formulae. 展开更多
关键词 multiple reaction monitoring quality control traditional Chinese medicine UPLC-ESI-MS/MS Yiqi jiangzhi Granules
原文传递
疏肝降脂汤联合门冬氨酸-鸟氨酸治疗病毒性肝炎后脂肪肝的临床效果
16
作者 张笑丹 苏江卫 +1 位作者 梁倞 梁平 《中国药师》 CAS 2023年第12期472-479,共8页
目的探讨中药疏肝降脂汤联合门冬氨酸-鸟氨酸(LOLA)治疗病毒性肝炎后脂肪肝的临床疗效及应用价值。方法纳入2018年10月至2020年10月在河北省胸科医院诊治的病毒性肝炎后脂肪肝患者为研究对象,随机分为对照组和试验组。对照组给予LOLA治... 目的探讨中药疏肝降脂汤联合门冬氨酸-鸟氨酸(LOLA)治疗病毒性肝炎后脂肪肝的临床疗效及应用价值。方法纳入2018年10月至2020年10月在河北省胸科医院诊治的病毒性肝炎后脂肪肝患者为研究对象,随机分为对照组和试验组。对照组给予LOLA治疗,试验组在对照组治疗的基础上给予疏肝降脂汤治疗,观察比较两组治疗前后肝功能、血脂及免疫功能变化情况。结果研究共纳入患者144例,对照组和试验组各72例。治疗后试验组总有效率为93.06%,显著高于对照组的79.17%(P<0.05)。治疗后,两组血清中丙氨酸氨基转移酶、天冬氨酸氨基转移酶、总胆红素、直接胆红素、谷氨酰转肽酶、总胆固醇、低密度脂蛋白胆固醇、甘油三酯显著降低(P<0.05),且试验组低于对照组(P<0.05)。两组高密度脂蛋白胆固醇值与CD4+T淋巴细胞比例高于治疗前(P<0.05),试验组高于对照组(P<0.05),但CD8+T淋巴细胞比例变化差异无统计学意义(P>0.05)。试验组脂肪肝超声分级优于对照组(P<0.05)。结论疏肝降脂汤联合门冬氨酸-鸟氨酸可改善病毒性肝炎后脂肪肝患者的免疫功能,提高患者肝功能,平衡血脂水平,持续改善患者的预后。 展开更多
关键词 脂肪肝 疏肝降脂汤 门冬氨酸-鸟氨酸 病毒性肝炎
原文传递
固本化湿降脂汤调控STING-IRF3通路对脾虚湿阻型单纯性肥胖大鼠炎症细胞因子的影响
17
作者 张琦 朱绚绚 +5 位作者 孙勇兵 王美君 谢情江 熊佳丽 周丽 陈浩 《广东药科大学学报》 CAS 2023年第2期86-93,共8页
目的 探讨固本化湿降脂汤通过STING-IRF3信号通路对脾虚湿阻型单纯性肥胖大鼠炎症细胞因子的影响。方法 建立脾虚湿阻型单纯性肥胖模型后,将大鼠随机分成模型组、奥利司他阳性对照组(37.5 mg/kg)、固本化湿降脂汤高剂量组(34.4 g/kg)、... 目的 探讨固本化湿降脂汤通过STING-IRF3信号通路对脾虚湿阻型单纯性肥胖大鼠炎症细胞因子的影响。方法 建立脾虚湿阻型单纯性肥胖模型后,将大鼠随机分成模型组、奥利司他阳性对照组(37.5 mg/kg)、固本化湿降脂汤高剂量组(34.4 g/kg)、中剂量组(17.2 g/kg)、低剂量组(8.6 g/kg)及正常组,每组8只,灌胃给药1次/d,连续4周。比较各组大鼠体质量、Lee’s系数、远红外热成像及脑部核磁共振成像(MRI),观察固本化湿降脂汤的减肥效果;比较各组大鼠炎症细胞因子如肿瘤坏死因子-α(TNF-α)、白细胞介素-6(IL-6)、白细胞介素-1β(IL-1β)、C反应蛋白(CRP)表达变化;采用免疫组织化学法检测脂肪中STING的表达;采用RT-PCR法检测肝脏STING的mRNA表达,使用蛋白印迹法在蛋白水平测量IRF3的变化,观察其对大鼠STING-IRF3信号通路的影响。结果 固本化湿降脂汤干预脾虚湿阻型单纯性肥胖大鼠后体质量下降明显(P<0.05),脑部、腹部异常区域恢复,可有效降低大鼠TNF-α、IL-6、IL-1β、CRP等相关炎症细胞因子的表达(P <0.01),用药前后STING-IRF3通路变化差异明显(P <0.01)。结论 固本化湿降脂汤通过调控STING-IRF3通路,降低脾虚湿阻型单纯性肥胖大鼠体质量并调节相关炎症细胞因子的表达。 展开更多
关键词 固本化湿降脂汤 脾虚湿阻型单纯性肥胖 炎症细胞因子 STING-IRF3通路
下载PDF
降脂膏治疗颈动脉硬化伴易损斑块患者的有效性研究
18
作者 丁颖颖 袁建兴 +1 位作者 章晓伟 吴晓新 《系统医学》 2023年第19期8-12,共5页
目的探讨降脂膏治疗颈动脉硬化伴易损斑块患者的有效性。方法选取2022年1月—2023年8月如皋市中医院脑病科收治的82例证属湿热瘀阻证的颈动脉易损斑块患者。将入选患者按门诊号最后位数字的奇偶性分为治疗组和对照组,每组41例。对照组... 目的探讨降脂膏治疗颈动脉硬化伴易损斑块患者的有效性。方法选取2022年1月—2023年8月如皋市中医院脑病科收治的82例证属湿热瘀阻证的颈动脉易损斑块患者。将入选患者按门诊号最后位数字的奇偶性分为治疗组和对照组,每组41例。对照组采用常规式药物干预,治疗组在药物干预基础上加用降脂膏。对比治疗后两种方法的有效性。结果治疗后,治疗组的颈动脉超声指标、血清学指标、CT血管造影指标优于对照组,差异有统计学意义(P<0.05);治疗组中医证候积分(13.43±1.46)分明显优于对照组(17.89±1.67)分,差异有统计学意义(t=12.874,P<0.05)。结论针对颈动脉硬化伴易损斑块患者,采用降脂膏治疗可以保证效果,体现出临床推广应用价值。 展开更多
关键词 降脂膏 颈动脉硬化 易损斑块 治疗效果
下载PDF
降浊消脂透皮贴联合降脂茶饮治疗超重/肥胖非酒精性脂肪性肝病的疗效观察
19
作者 魏方 安颂歌 +2 位作者 段倩倩 牛琼 陈琳 《中西医结合肝病杂志》 CAS 2023年第11期986-988,995,共4页
目的:探讨降浊消脂透皮贴贴敷联合降脂茶饮对超重/肥胖非酒精性脂肪性肝病(痰湿内阻型)患者的治疗效果。方法:选取我院2021年5月至2023年5月的超重/肥胖非酒精性脂肪性肝病(痰湿内阻型)住院患者80例,按入院顺序随机分为对照组和干预组,... 目的:探讨降浊消脂透皮贴贴敷联合降脂茶饮对超重/肥胖非酒精性脂肪性肝病(痰湿内阻型)患者的治疗效果。方法:选取我院2021年5月至2023年5月的超重/肥胖非酒精性脂肪性肝病(痰湿内阻型)住院患者80例,按入院顺序随机分为对照组和干预组,每组40例。对照组患者口服多烯磷脂酰胆碱胶囊治疗,干预组患者采用降浊消脂透皮贴贴敷肝区联合降脂茶饮治疗,疗程均为8周。比较两组患者治疗前后血清学指标(ALT、AST、TG、TC)、BMI指数、腰围、腹围、臀围等指标,并观察临床疗效。结果:治疗8周后两组患者ALT、AST、TC、TG水平均显著低于治疗前(P<0.01),干预组患者各血清学指标均低于对照组(P<0.05);对照组患者的BMI指数、腰围、臀围较治疗前显著改善(P<0.05),腹围无明显改善(P>0.05)。干预组BMI指数、腰围、腹围、臀围显著改善(P<0.05),而且改善程度显著优于对照组(P<0.05);且干预组肝脏超声有效率(95.00%)高于对照组(75.00%)(P<0.05),干预组临床总有效率(97.50%)明显优于对照组(77.50%)(P<0.05)。结论:自拟降浊消脂透皮贴贴敷联合降脂茶饮可减轻超重/肥胖非酒精性脂肪性肝病(痰湿内阻型)患者的症状和体征,促进肝功能恢复,降低血脂水平,改善肝脏超声下脂肪肝分级水平,且能有效减轻患者体重及腰围、腹围、臀围。 展开更多
关键词 非酒精性脂肪性肝病 降浊消脂透皮贴 贴敷疗法 降脂茶饮 肥胖
下载PDF
降脂理肝汤联合水飞蓟宾对非酒精性脂肪肝患者肝功能及血脂水平的影响
20
作者 张继跃 张一典 刘成全 《中国中医药现代远程教育》 2023年第18期107-110,共4页
目的 探讨降脂理肝汤联合水飞蓟宾对非酒精性脂肪肝患者肝功能及血脂水平的影响。方法 选取2018年12月—2021年12月淮安市妇幼保健院收治的非酒精性脂肪肝患者92例,依据随机数字表法,分成对照组(46例)、观察组(46例)。对照组给予水飞蓟... 目的 探讨降脂理肝汤联合水飞蓟宾对非酒精性脂肪肝患者肝功能及血脂水平的影响。方法 选取2018年12月—2021年12月淮安市妇幼保健院收治的非酒精性脂肪肝患者92例,依据随机数字表法,分成对照组(46例)、观察组(46例)。对照组给予水飞蓟宾胶囊治疗,观察组给予降脂理肝汤联合水飞蓟宾胶囊治疗,2组治疗时间都为3个月,比较2组各项指标。结果 治疗后观察组临床总有效率97.83%(45/46)高于对照组的82.61%(38/46)(P<0.05);与治疗前比,2组治疗后中医证候各项积分、血清谷丙转氨酶(ALT)、谷草转氨酶(AST)、谷氨酰转肽酶(GGT)、总胆固醇(TC)、三酰甘油(TG)、低密度脂蛋白胆固醇(LDL-C)水平,体质量、腰围、臀围均降低,且与对照组比,观察组相关指标处于更低水平(P<0.05);2组治疗后血清高密度脂蛋白胆固醇(HDL-C)水平均升高,且与对照组比,观察组HDL-C指标处于更高水平(P<0.05)。结论 对于非酒精性脂肪肝患者,应用降脂理肝汤联合水飞蓟宾治疗可有效缓解其临床症状,改善肝功能,降低血脂水平,促进机体康复。 展开更多
关键词 肝癖 非酒精性脂肪肝 降脂理肝汤 水飞蓟宾 中医药疗法
下载PDF
上一页 1 2 30 下一页 到第
使用帮助 返回顶部